Jade Biosciences, Inc. (JBIO) Balance Sheet
JBIO balance sheet, 2025
December 31, 2025 · U.S. dollars$349.8M assets = $17.3M liabilities + $332.5M equity
Both columns are drawn to the same scale: what JBIO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
JBIO financial health
Descriptive bands, not a rating. Fiscal 2025.
JBIO balance sheet trends, 2020–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $4.7M2020 | $349.8M2025 | +136.6%/yr | |
| Total liabilities | $1.8M2020 | $17.3M2025 | +57.6%/yr | |
| Shareholders’ equity | $2.9M2020 | $332.5M2025 | +157.4%/yr | |
| Cash & short-term investments | $4.6M2020 | $336.2M2025 | +136.2%/yr | |
| Total debt | $574,0002021 | $724,0002025 | +6.0%/yr | |
| Net cash (debt) | $166.8M2021 | $335.4M2025 | +$168.6M | |
| Working capital | $2.9M2020 | $319.6M2025 | +$316.7M | |
| Debt / equity | 0.002021 | 0.002025 | 0.00 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
JBIO assets
JBIO liabilities and equity
JBIO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
JBIO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & short-term investments | $336.2M | $78.6M | $122.4M | $129.2M | $167.4M | $4.6M |
| Cash & equivalents | $88.4M | $33.8M | $23.5M | $22.4M | $54.2M | $4.6M |
| Short-term investments | $247.7M | $44.9M | $98.9M | $106.8M | $113.2M | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $0 | $1.5M | $1.8M | $2.3M | $7.0M | $103,000 |
| Total current assets | $336.2M | $80.1M | $124.2M | $131.5M | $174.3M | $4.7M |
| Property, plant & equipment (net) | $896,000 | $215,000 | $902,000 | $1.2M | $728,000 | $39,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $12.7M | $0 | $2.3M | $2.6M | $302,000 | $0 |
| Total assets | $349.8M | $80.3M | $127.4M | $135.3M | $175.4M | $4.7M |
| Liabilities | ||||||
| Accounts payable | $2.2M | $224,000 | $2.4M | $2.6M | $1.2M | $618,000 |
| Short-term debt | — | $417,000 | $420,000 | $385,000 | $192,000 | — |
| Total current liabilities | $16.5M | $3.8M | $17.6M | $7.8M | $2.5M | $1.8M |
| Long-term debt | $0 | $107.6M | $0 | $0 | $0 | $0 |
| Lease obligations | $724,000 | $0 | — | — | — | — |
| Other long-term liabilities | $724,000 | $0 | $324,999 | $775,999 | $395,000 | $0 |
| Total liabilities | $17.3M | $3.9M | $18.0M | $8.6M | $2.9M | $1.8M |
| Shareholders' equity | ||||||
| Common stock & paid-in capital | $5,000 | $3,000 | $3,000 | $2,000 | $2,000 | — |
| Retained earnings (deficit) | −$174.4M | −$233.1M | −$163.4M | −$87.9M | −$36.4M | −$13.4M |
| Accumulated other comprehensive income | $129,000 | $105,000 | $237,000 | −$466,000 | −$59,000 | — |
| Total shareholders' equity | $332.5M | $76.4M | $109.5M | $126.7M | $172.4M | $2.9M |
| Key figures | ||||||
| Total debt | $724,000 | $417,000 | $675,000 | $1.1M | $574,000 | — |
| Net cash (debt) | $335.4M | $78.2M | $121.8M | $128.1M | $166.8M | — |
| Working capital | $319.6M | $76.3M | $106.6M | $123.7M | $171.8M | $2.9M |
| Tangible book value | $332.5M | $76.4M | $109.5M | $126.7M | $172.4M | $2.9M |
| Book value per share | $10.60 | — | — | — | — | — |
| Shares outstanding | 31.4M | — | — | — | — | — |
| Current ratio | 20.33 | 20.93 | 7.04 | 16.90 | 68.37 | 2.64 |
| Quick ratio | 20.33 | 20.54 | 6.94 | 16.60 | 65.64 | 2.58 |
| Debt / equity | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | — |
| Equity / assets | 95.1% | 95.1% | 85.9% | 93.7% | 98.3% | 62.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $461.2M | $311.3M | $336.2M | $198.9M | $220.9M | $76.2M | $78.6M | $88.7M | $104.2M | $99.3M | $122.4M | $135.2M |
| Cash & equivalents | $107.2M | $55.1M | $88.4M | $50.1M | $220.9M | $44.2M | $33.8M | $31.1M | $31.1M | $9.1M | $23.5M | $32.2M |
| Short-term investments | $354.0M | $256.2M | $247.7M | $148.8M | — | $32.0M | $44.9M | $57.6M | $73.1M | $90.2M | $98.9M | $103.0M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $10.0M | $7.2M | $0 | $2.5M | $2.0M | $1.2M | $1.5M | $1.9M | $6.6M | $3.9M | $1.8M | $2.4M |
| Total current assets | $471.3M | $318.5M | $336.2M | $201.4M | $223.0M | $77.4M | $80.1M | $90.6M | $110.8M | $103.2M | $124.2M | $137.6M |
| Property, plant & equipment (net) | $793,000 | $847,000 | $896,000 | $916,000 | $924,000 | $160,000 | $215,000 | $273,000 | $853,000 | $985,000 | $902,000 | $1.0M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $69,000 | $69,000 | $12.7M | $174,000 | $60,000 | $0 | $0 | $81,000 | $81,000 | $2.6M | $2.3M | $2.2M |
| Total assets | $472.1M | $319.4M | $349.8M | $202.4M | $224.0M | $77.5M | $80.3M | $91.0M | $111.7M | $106.8M | $127.4M | $140.9M |
| Liabilities | ||||||||||||
| Accounts payable | $6.6M | $4.0M | $2.2M | $1.4M | $7.6M | $69,000 | $224,000 | $908,000 | $4.2M | $3.3M | $2.4M | $3.5M |
| Short-term debt | — | — | — | — | — | $312,000 | $417,000 | $459,000 | $475,000 | $445,000 | $420,000 | $451,000 |
| Total current liabilities | $31.6M | $22.3M | $16.5M | $22.4M | $21.6M | $2.4M | $3.8M | $10.3M | $17.0M | $15.5M | $17.6M | $14.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $96.7M | $0 | $0 | $0 | $0 |
| Lease obligations | $628,000 | $679,000 | $724,000 | $747,000 | $792,000 | — | — | — | — | — | — | — |
| Other long-term liabilities | $628,000 | $678,999 | $724,000 | $747,000 | $792,000 | $70,000 | $70,000 | $0 | $275,999 | $398,999 | $324,999 | $428,000 |
| Total liabilities | $32.2M | $23.0M | $17.3M | $23.1M | $22.4M | $2.5M | $3.9M | $10.5M | $17.3M | $15.9M | $18.0M | $15.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $6,000 | $5,000 | $5,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 |
| Retained earnings (deficit) | −$270.5M | −$214.8M | −$174.4M | −$142.5M | −$117.3M | −$235.6M | −$233.1M | −$227.6M | −$211.4M | −$186.6M | −$163.4M | −$143.0M |
| Accumulated other comprehensive income | −$660,000 | −$342,000 | $129,000 | $29,000 | −$24,000 | $50,000 | $105,000 | $224,000 | −$83,000 | −$33,000 | $237,000 | −$195,000 |
| Total shareholders' equity | $439.9M | $296.5M | $332.5M | $179.3M | $201.6M | $75.0M | $76.4M | $80.5M | $94.4M | $90.9M | $109.5M | $125.7M |
| Key figures | ||||||||||||
| Total debt | $628,000 | $679,000 | $724,000 | $747,000 | $792,000 | $312,000 | $417,000 | $540,000 | $681,000 | $774,000 | $675,000 | $809,000 |
| Net cash (debt) | $460.6M | $310.6M | $335.4M | $198.2M | $220.2M | $75.9M | $78.2M | $88.2M | $103.5M | $98.6M | $121.8M | $134.4M |
| Working capital | $439.7M | $296.2M | $319.6M | $179.0M | $201.4M | $75.0M | $76.3M | $80.3M | $93.7M | $87.7M | $106.6M | $122.9M |
| Tangible book value | $439.9M | $296.5M | $332.5M | $179.3M | $201.6M | $75.0M | $76.4M | $80.5M | $94.4M | $90.9M | $109.5M | $125.7M |
| Book value per share | $7.21 | $5.13 | $6.74 | $4.53 | $7.09 | — | — | — | — | — | — | — |
| Shares outstanding | 61.1M | 57.8M | 49.3M | 39.6M | 28.4M | — | — | — | — | — | — | — |
| Current ratio | 14.93 | 14.29 | 20.33 | 9.01 | 10.31 | 32.01 | 20.93 | 8.78 | 6.51 | 6.65 | 7.04 | 9.34 |
| Quick ratio | 14.61 | 13.96 | 20.33 | 8.90 | 10.22 | 31.53 | 20.54 | 8.60 | 6.12 | 6.40 | 6.94 | 9.18 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Equity / assets | 93.2% | 92.8% | 95.1% | 88.6% | 90.0% | 96.8% | 95.1% | 88.5% | 84.5% | 85.1% | 85.9% | 89.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 6, 2026); data from EODHD.
JBIO financial position
At the end of fiscal 2025 (December 31, 2025), Jade Biosciences had total assets of $349.8 million (up 335.4% from a year earlier), total liabilities of $17.3 million and shareholders' equity of $332.5 million. It held $336.2 million in cash and short-term investments against $0.7 million of debt, a net cash position of $335.4 million. Its current ratio was 20.33. In the latest quarter (ended June 30, 2026) total assets were $472.1 million and equity $439.9 million.
Related: JBIO income statement, JBIO cash flow statement, JBIO key metrics. See the JBIO stock overview for the latest quote and news.
JBIO balance sheet FAQ
What are Jade Biosciences's total assets?
Jade Biosciences reported total assets of $349.8 million at the end of fiscal 2025 (December 31, 2025), compared with $80.3 million a year earlier.
How much debt does Jade Biosciences have?
Jade Biosciences had $0.7 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.00.
How much cash does Jade Biosciences have?
Jade Biosciences held $336.2 million in cash and short-term investments at the end of fiscal 2025; with $0.7 million of debt that is net cash of $335.4 million.
What is Jade Biosciences's book value?
Jade Biosciences's shareholders' equity (book value) was $332.5 million at the end of fiscal 2025, or $10.60 per share.
What is Jade Biosciences's current ratio?
Jade Biosciences had current assets of $336.2 million and current liabilities of $16.5 million, a current ratio of 20.33 (it can cover its short-term obligations).